FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
105 letters match. Newest first.
-
DrugsZhejiang Uniquality Nursing Products Technology Co., Ltd. dba ZheJiang YouQuan Care Products Technology Co., Ltd.
FDA warns Zhejiang Uniquality over inadequate OTC drug component testing and quality oversight; import alert issued.
High risk -
DrugsUnexo Lifesciences, Private Limited
FDA warned Unexo Lifesciences over serious CGMP violations, including data integrity failures and torn batch records for U.S.-bound drugs.
High risk -
DrugsZhejiang Qimei Cosmetics Co., Ltd.
Zhejiang Qimei Cosmetics drew an FDA warning for CGMP violations in sterile-labeled OTC isopropyl alcohol prep pads.
High risk -
DrugsAnalytical Food Laboratories, Inc.
FDA warned contract testing lab Analytical Food Laboratories after inspection found unvalidated drug test methods and weak quality oversight.
High risk -
FoodTop Health Manufacturing, LLC
Top Health Manufacturing's dietary supplements violated manufacturing and labeling rules, FDA says.
Medium -
DrugsMedOffice Saglik Endustri Anonim Sirketi
FDA warned MedOffice Saglik after an inspection found missing batch release testing and inadequate process validation for over-the-counter drugs.
High risk -
DrugsSoliteint Kozmetikai KFT
Hungarian contract maker Soliteint Kozmetikai failed to test OTC pain-relief drugs and ingredients, FDA says; U.S. production halted.
High risk -
DrugsOmni Lens Pvt. Ltd.
FDA warns Omni Lens about CGMP failures and misbranding of ophthalmic OTC drugs made by unregistered contract manufacturers.
High risk -
DrugsOutin Futures Corp.
FDA warned Outin Futures, a Korean drug manufacturer, of CGMP violations and sunscreen misbranding after a March 2024 inspection.
High risk -
DrugsLittle Moon Essentials, LLC
FDA warns Little Moon Essentials over CGMP failures and unapproved topical analgesic drugs made in Dania Beach, Florida.
High risk -
DrugsClean Solutions LLC
FDA warned Clean Solutions LLC that its OTC hand soaps and sanitizer were adulterated because it released drugs without component or finished-product testing.
High risk -
DrugsAromas Para El Alma S.A.
Aromas Para El Alma, a Costa Rica drug manufacturer, made EREWHON hand sanitizer/spray subpotent and broke manufacturing rules.
High risk -
DrugsGreco Gas, Inc.
Greco Gas, Inc. released medical gases without identity or purity testing and without quality oversight.
High risk -
DrugsTJA Health, LLC
FDA warns TJA Health LLC over unsafe drug manufacturing of toothpaste and mouth rinse due to untested components and poor quality control.
High risk -
DrugsOrean Personal Care Ltd.
FDA warned Orean Personal Care Ltd. that repeat manufacturing failures make its OTC drugs adulterated.
High risk -
DrugsLS Promotions Inc.
LS Promotions Inc. failed to adequately test and validate its OTC sunscreens, lip balm and hand sanitizer, making them adulterated drugs.
High risk -
DrugsGuangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.
FDA warned Guangzhou Baiyunshan Jingxiutang Pharmaceutical over current good manufacturing practice violations in over-the-counter drug manufacturing, including inadequate specs and microbial testing.
High risk -
DrugsOmega Tech Labs LLC
Omega Tech Labs in Boise, Idaho, released microbially contaminated combination drug-device product and failed manufacturing rules.
High risk -
DrugsJiangsu Hengrui Pharmaceuticals Co., Ltd.
FDA found data integrity failures and inadequate sterile manufacturing controls at Jiangsu Hengrui Pharmaceuticals' drug facility.
High risk -
DrugsBiomic Sciences, LLC dba ION Intelligence of Nature
Biomic Sciences' nasal spray was grossly contaminated with microorganisms, and FDA also found manufacturing and labeling violations.
High risk -
DrugsSeatex, LLC
FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.
High risk -
DrugsCentral Admixture Pharmacy Services, Inc.
FDA warned sterile drug compounder Central Admixture Pharmacy Services (Phoenix) that dirty areas and weak sterility testing made its drugs adulterated.
High risk -
DrugsSeatex, LLC
Seatex, LLC made OTC hand sanitizer drugs with inadequate current good manufacturing practice (CGMP), including shared equipment with industrial chemicals and missing component testing.
High risk -
DrugsFirstCham Co., Ltd.
FDA warns FirstCham over current good manufacturing practice violations and misbranding of Soo'Ae hand sanitizing wipes.
High risk -
DrugsDeqing Jiarou Daily Chemical Co., Ltd.
Deqing Jiarou failed current good manufacturing practice (CGMP) for OTC hand sanitizer, including no methanol testing of ethanol.
High risk -
DrugsThai Nakorn Patana Co., Ltd.
FDA warns Thai Nakorn Patana over manufacturing quality violations, including missing identity and strength testing before release of OTC drugs.
High risk -
DrugsS & J International Enterprises Public Company Limited
FDA cited S & J International Enterprises for CGMP violations, data integrity failures, and limiting access to records during a drug inspection.
High risk -
DrugsColonial Dames Company, Ltd
FDA warns Colonial Dames of manufacturing violations and unapproved acne drug claims for Oxygenetix.
High risk -
DrugsNational Chemical Laboratories
National Chemical Laboratories’ OTC topical drugs were adulterated after FDA found manufacturing quality violations, including untested BZK and weak quality oversight.
High risk -
DrugsSeoul Cosmetics Co., Ltd.
FDA warned Seoul Cosmetics, a South Korean drug maker, over poor manufacturing quality and unapproved OTC drugs.
High risk -
DrugsPureChemPros LLC
FDA warns PureChemPros over manufacturing quality failures and unapproved, misbranded hand sanitizer and hydrogen peroxide drugs.
High risk -
DrugsLCC Ltd.
LCC Ltd., an OTC drug maker, lacked identity testing for risky ingredients and adequate quality oversight, FDA says.
High risk -
DrugsIntas Pharmaceuticals Limited
FDA warned Intas Pharmaceuticals about serious manufacturing-quality violations, including data integrity failures and inaccurate environmental monitoring, at its India drug plant.
High risk -
DrugsMedgel Private Limited
FDA cited Medgel Private Limited, an Indian OTC drug maker, for manufacturing violations including poor investigations and data integrity failures.
High risk -
DrugsAvlon Industries, Inc.
FDA warned Avlon Industries that its over-the-counter drug manufacturing broke quality rules, citing missing identity tests for high-risk glycerin/propylene glycol and validation failures.
High risk -
DrugsMr. Lulu LLC
FDA warned Mr. Lulu LLC of Claremont, California, that its OTC sunscreen drops were adulterated: no release testing, no identity testing, no batch records.
High risk -
DrugsPharmedica USA, LLC
FDA found Pharmedica made ophthalmic and nasal drugs under insanitary conditions without required sterile controls.
High risk -
DrugsZermat International S.A. de C.V.
FDA warns Zermat International about current good manufacturing practice violations for OTC drugs, including releasing out-of-specification lots without investigation.
High risk -
DrugsCosmetic Science Laboratories LLC
FDA warned Cosmetic Science Laboratories about OTC sunscreen drugs made without required manufacturing controls.
High risk -
DrugsMidlab Incorporated
FDA cited Midlab in Athens, Tennessee for manufacturing violations and unapproved, misbranded hand sanitizer and antibacterial soap drugs.
High risk -
DrugsUltra Chem Labs Corporation
FDA warns Ultra Chem Labs about methanol-tainted hand sanitizer sold as an unapproved, misbranded drug.
High risk -
DrugsClean Cosmetics LLC
FDA warned Clean Cosmetics LLC over manufacturing failures in OTC hand sanitizer, including ethanol contaminated with methanol.
High risk -
DrugsKari Gran Inc.
Kari Gran Inc. released OTC SPF sunscreen drugs without adequate batch testing or stability data.
High risk -
DrugsShuzy Rock Inc.
FDA warns Shuzy Rock Inc. of adulterated hand sanitizers made under insanitary conditions and found below labeled alcohol strength.
High risk -
DrugsAdvanced Cosmetic Research Laboratories Inc.
FDA cited Advanced Cosmetic Research Laboratories for manufacturing-quality violations at its Chatsworth drug plant and an unapproved 5% lidocaine cream.
High risk -
DrugsDSP Skin Care LLC
FDA cites DSP Skin Care for manufacturing failures and unapproved, misbranded Hongosan antifungal drugs.
High risk -
DrugsGenlabs Corporation
FDA warns Genlabs Corporation of Chino, California, that its OTC hand soaps are adulterated and misbranded after finding serious CGMP failures.
High risk -
DrugsMonarch PCM, LLC
Monarch PCM, LLC made unapproved skin drugs and broke manufacturing rules, with microbial contamination and weak investigations.
High risk -
DrugsVitae Enim Vitae Scientific Inc.
FDA warned Vitae Enim Vitae Scientific of sterile drug CGMP violations and contamination-control failures after a 2021 inspection, leading to a recall.
High risk -
DevicesSunstar Americas, Inc.
Sunstar Americas' water and quality failures led to contamination and recalls of oral rinses and dry-mouth devices.
High risk